Skip to main content
. Author manuscript; available in PMC: 2011 Mar 11.
Published in final edited form as: BJU Int. 2010 Sep 22;107(6):924–928. doi: 10.1111/j.1464-410X.2010.09679.x

TABLE 1.

Clinical and pathological characteristics of men in the SEARCH database who started ADT after RP stratified by whether they gained weight or lost weight/had no change in the weight in the first year of ADT

Variable Total Weight gainers Weight losers P*
No. of patients (%) 132 92 (70) 40 (30)
Mean (sd):
  weight change, kg 2.2 (4.1) 4.2 (2.9) −2.4 (2.4)
  age at ADT, years 66 (8) 66 (8) 66 (8) 0.81
Median (IQR):
  year of ADT 2003 (‘01–‘05) 2003 (‘01–‘05) 2003 (‘01–‘05) 0.75
N (%):
Race: 0.25
  White 66 (50) 47 (51) 19 (48)
  Black 56 (42) 36 (39) 20 (50)
  Other 10 (8) 9 (10) 1 (2)
Centre: 0.61
  1 38 (29) 27 (29) 11 (27)
  2 26 (20) 20 (22) 6 (15)
  3 16 (12) 12 (13) 4 (10)
  4 52 (39) 33 (36) 19 (48)
Mean (sd):
  pre-ADT BMI, kg/m2 29.0 (4.8) 28.4 (4.4) 30.0 (5.5) 0.10
Median (IQR):
  pre-ADT PSA level, ng/mL 1.0 (0.2–4.8) 1.0 (0.2–5.6) 1.2 (0.4–2.8) 0.86
N (%):
Pathological Gleason: 0.74
  ≤6 22 (17) 15 (16) 7 (18)
  3 + 4 46 (35) 34 (37) 12 (30)
  ≥4 + 3 64 (48) 43 (47) 21 (53)
Extracapsular extension: 0.33
  positive 57 (44) 42 (47) 15 (38)
  negative 73 (56) 48 (53) 25 (63)
Surgical margins: 0.56
  positive 91 (31) 62 (67) 29 (73)
  negative 41 (69) 30 (33) 11 (27)
Seminal vesicle invasion: 0.99
  positive 46 (35) 32 (35) 14 (35)
  negative 85 (65) 59 (65) 26 (65)
Lymph node status: 0.68
  0 100 (76) 71 (77) 29 (73)
  1 8 (6) 6 (7) 2 (5)
  2 24 (18) 15 (16) 9 (22)
*

P-value from chi-squared except where noted;

P-value from t-test;

rank sum.